Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride in Chronic Central Serous Chorioretinopathy
NCT01585441Phase 2Terminated
- Sponsor
- National Eye Institute
- Start
- Apr 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of finasteride in Central Serous Chorioretinopathy (CSCR), sponsored by National Eye Institute. Started Apr 2012; status: terminated.
02
Drugs
finasteride
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT01585441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01585441.